Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SARGRAMOSTIM vs SECNIDAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SARGRAMOSTIM vs SECNIDAZOLE: Safety Overview

Metric SARGRAMOSTIM SECNIDAZOLE
Total FAERS Reports 593 245
Deaths Reported 85 1
Death Rate 14.3% 0.4%
Hospitalizations 138 10
Average Patient Age 34.4 yrs 40.4 yrs
% Female Patients 43.5% 95.6%
FDA Approval Date N/A Sep 15, 2017
Manufacturer Partner Therapeutics, Inc. Evofem Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription